Replication interference between human papillomavirus types 16 and 18 mediated by heterologous E1 helicases.
BACKGROUND
Co-infection of multiple genotypes of human papillomavirus (HPV) is commonly observed among women with abnormal cervical cytology, but how different HPVs interact with each other in the same cell is not clearly understood. A previous study using cultured keratinocytes revealed that genome replication of one HPV type is inhibited by co-existence of the genome of another HPV type, suggesting that replication interference occurs between different HPV types when co-infected; however, molecular mechanisms underlying inter-type replication interference have not been fully explored.


METHODS
Replication interference between two most prevalent HPV types, HPV16 and HPV18, was examined in HPV-negative C33A cervical carcinoma cells co-transfected with genomes of HPV16 and HPV18 together with expression plasmids for E1/E2 of both types. Levels of HPV16/18 genome replication were measured by quantitative real-time PCR. Physical interaction between HPV16/18 E1s was assessed by co-immunoprecipitation assays in the cell lysates.


RESULTS
The replication of HPV16 and HPV18 genomes was suppressed by co-expression of E1/E2 of heterologous types. The interference was mediated by the heterologous E1, but not E2. The oligomerization domain of HPV16 E1 was essential for HPV18 replication inhibition, whereas the helicase domain was dispensable. HPV16 E1 co-precipitated with HPV18 E1 in the cell lysates, and an HPV16 E1 mutant Y379A, which bound to HPV18 E1 less efficiently, failed to inhibit HPV18 replication.


CONCLUSIONS
Co-infection of a single cell with both HPV16 and HPV18 results in replication interference between them, and physical interaction between the heterologous E1s is responsible for the interference. Heterooligomers composed of HPV16/18 E1s may lack the ability to support HPV genome replication.
Pathogen Genomics Center, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashi-murayama, Tokyo 208-0011, Japan. moris@nih.go.jp.
Seiichiro
S
Mori
Rika
R
Kusumoto-Matsuo
Yoshiyuki
Y
Ishii
Takamasa
T
Takeuchi
Iwao
I
Kukimoto
D045744:Cell Line, Tumor; D004847:Epithelial Cells / Q000821:virology; D005260:Female; D052162:Human papillomavirus 16 / Q000201:enzymology / Q000235:genetics / Q000502:physiology*; D052161:Human papillomavirus 18 / Q000201:enzymology / Q000235:genetics / Q000502:physiology*; D006801:Humans; D047468:Immunoprecipitation; D009856:Oncogene Proteins, Viral / Q000235:genetics / Q000378:metabolism*; D060888:Real-Time Polymerase Chain Reaction; D014162:Transfection; D014762:Viral Interference; D014779:Virus Replication
C093478:E1 protein, Human papillomavirus 16; D009856:Oncogene Proteins, Viral; C084762:oncogene protein E1, Human papillomavirus type 18